SCHEMBL31228211

SCHEMBL31228211

NC(=O)c1cn([C@@H]2O[C@](F)(CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 16/20 0.59
▸ NPC1 O15118 1/20 0.51
▸ GALR3 O60755 1/20 0.51
▸ S1PR4 O95977 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ S1PR1 P21453 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ PAX8 Q06710 1/20 0.51
▸ HASPIN Q8TF76 1/20 0.43
▸ DOT1L Q8TEK3 1/20 0.41
▸ CDK1 P06493 1/20 0.40
▸ CCNB1 P14635 1/20 0.40
▸ CCNA2 P20248 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ CCNA1 P78396 1/20 0.40
▸ PRMT5 O14744 1/20 0.39
▸ WDR77 Q9BQA1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31228088 0.86 ADK (0.45) ADKNPC1GALR3S1PR4ALDH1A1
SCHEMBL31228253 0.86 ADK (0.51) ADKNPC1GALR3S1PR4ALDH1A1
SCHEMBL31228437 0.85 ADK (0.50) ADKNPC1GALR3S1PR4ALDH1A1
SCHEMBL31228180 0.85 ADK (0.50) ADKNPC1GALR3S1PR4ALDH1A1
SCHEMBL31228221 0.83 ADK (0.42) ADKNPC1GALR3S1PR4ALDH1A1
SCHEMBL18483552 0.83 ADK (0.42) ADKNPC1GALR3S1PR4ALDH1A1
SCHEMBL31228230 0.83 ADK (0.48) ADKNPC1GALR3S1PR4ALDH1A1
SCHEMBL31228142 0.82 CDK1 (0.39) ADKNPC1GALR3S1PR4ALDH1A1
SCHEMBL31228248 0.82 ADK (0.60) ADKNPC1GALR3S1PR4ALDH1A1
SCHEMBL31725296 0.77 PRMT5 (0.47) ADKNPC1GALR3S1PR4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP claimed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO claimed
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP disclosed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO disclosed
Send feedback